Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Ugo Paolucci"'
Publikováno v:
Metabolomics. 1:75-85
Metabolic serotypes sensitive to caloric intake may enable sera metabolomic profiles to validate epidemiological parameters and predict disease risk in humans. This long-range goal is complicated by the lack of known state markers and the requirement
Publikováno v:
Stroke. 45
Introduction: Comprehensive stroke centers (CSCs) have been shown to improve clinical outcomes and mitigate disparities in treatment of ischemic stroke patients. CSCs likely also improve outcomes in stroke patients with hemorrhagic stroke. Methods: W
Autor:
Arthur M. Pancioli, Opeolu Adeoye, Pamela A. Schmit, Jane Khoury, Steven R. Levine, Thomas A. Tomsick, Heidi Sucharew, Claudette E. Brooks, Todd J. Crocco, Laurie Gutmann, Thomas M. Hemmen, Scott E. Kasner, Dawn Kleindorfer, William A. Knight, Sharyl Martini, James S. McKinney, William J. Meurer, Brett C. Meyer, Alexander Schneider, Phillip A. Scott, Sidney Starkman, Steven Warach, Joseph P. Broderick, Joseph Broderick, Scott Janis, Thomas Tomsick, Todd Crocco, Thomas Hemmen, Alex Schneider, Steven Levine, Claudia Moy, K. Michael Welch, Gretchen Tietjen, William R. Clarke, Jordan Bonomo, Erin McDonough, Simona Ferioli, Felipe de los Rios De la Rosa, Daniel Woo, Rachel Garvin, Pooja Khatri, Anna Gensic, Matthew Flaherty, Daniel Kanter, Brett Kissela, Brian Stettler, Jason Mackey, Rhonda Cadena, Shannon Kohake, Laura Heitsch, Samir Belagaje, Achala Vagal, John Hallenbeck, Richard Benson, Amie Hsia, Rakesh Jaitly, Lawrence Latour, John Lynch, Jose Merino, Ravi Menon, Jason Freeman, Alejandro Magadan, Nandakumar Magaraja, Jennifer Jothen, Bonanle Famakin, Shlee Song, Alex Katcheves, Zurab Nadareishvili, Carsen Ritter, William Barsan, Devin Brown, Lewis Morgenstern, Robert Silbergleit, Venkatakrishna Rajajee, Lesli Rusche-Skolarus, Jim Burke, Jeffrey Fletcher, Eric Adelman, Michael Wang, Darin Zahuranec, Brett Cucchiara, Steven Messe, Christina Wilson, Koto Ishida, Michael Mullen, Jonathan Raser, Swaroop Pawar, David Rose, Neelofer Shafi, Igor Rybinnik, Michael McGavery, Lauren Beslow, Lauren Sansing, Latisha Ali, Hermelinda Abcede, Peter Adamczyk, William Buxton, Michael Froehler, Doojin Kim, David Liebeskind, Bruce Ovbiagele, Verna Porter, Neal Rao, Radoslav Raychev, Sarah Song, Jeffrey Saver, Matthew Tenser, Shamsha Velani, Anil Yallapragada, Brett Meyer, Any Guzik, Kiet Loc, Dawn Meyer, Gilda Tafreshi, Jessica Choe, Ajeet Sodhi, Patrick Delaney, Sean Evans, Omar A. Ghausi, Nhu Bruce, Will Neil, Brank Huisa, Andrew Stemer, Reid Taylor, Jeanette Larson, Seth Larson, Rodney Leacock, Subasisni Dash, Robert Eisenstein, Raffi Kapitanyan, Ugo Paolucci, Chirag Shah, Win Toe, John Brick, Owen Lander, Hollynn Larrabee, Joseph Minardi, Allison Tadros, Roger Tillotson, Charles Whiteman, Debra Paulson, Rosanna Sikora, Christopher Cummings, John Foster, Janice Carrozzella, Traci Doellman, Irene Ewing, Jamey Frasure, Emily Goodall, Pamela Kimmel, Judith Spilker, Robert Tamer, Peggy Waymeyer, Joyce Zeigler, Lisa Davis, Saman Farsad, Teresa Morella, Allison Kade, Shirley Frederiksen, Mary Liz, Jean Luciano, Judy Guzy, Ileana Grunberg, Teresa Rzesiewicz, Karen Rapp, Tracy Nanney, Leslie Shell, Margaret Perkins, Cindy Benton, Robin Jones, Lynne Hampton, Claudine Cuento, Rachel Alosky, Stephanie Shepard, Michelle Moccio, Catherine Albrecht, Yaritza Rosario, Deborah Caputo, Stephen Davis, Patricia Altemus, Martha Power, Reyna VanGilder, Jay Sherman, Taura Barr
Background and Purpose— In a previous study, 0.3 and 0.45 mg/kg of intravenous recombinant tissue plasminogen activator (rt-PA) were safe when combined with eptifibatide 75 mcg/kg bolus and a 2-hour infusion (0.75 mcg/kg per minute). The Combined A
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4b860e2473bebcad13f911363ee57748
https://europepmc.org/articles/PMC3970761/
https://europepmc.org/articles/PMC3970761/
Publikováno v:
Stroke. 43
Introduction--- Advances in emergent treatment and hospital management of acute ischemic stroke (AIS) have decreased in-hospital mortality. Despite this early reduction in mortality, prior research has indicated that up to 25% of patients hospitalize
Publikováno v:
Stroke. 43
Introduction--- Stroke is becoming increasingly more prevalent in women. Prior studies of sex differences in stroke mortality have reported variable findings. Although crude stroke fatality is higher in women, this appears to be mediated by age and o
Autor:
Jawad F. Kirmani, Ugo Paolucci
Publikováno v:
Journal of neuroimaging : official journal of the American Society of Neuroimaging. 22(2)
Intracranial aneurysms undergoing balloon-assisted endovascular repair are particularly challenging given the concurrent use of one or more catheters in addition to the primary coiling microcatheter. Here, we describe a previously unreported novel de
Autor:
Ugo Paolucci, Wayne R. Matson, Bruce S. Kristal, Karen E. Vigneau-Callahan, Honglian Shi, Paul E. Milbury
Publikováno v:
Omics : a journal of integrative biology. 8(3)
Dietary restriction (DR)-induced changes in the serum metabolome may be biomarkers for physiological status (e.g., relative risk of developing age-related diseases such as cancer). Megavariate analysis (unsupervised hierarchical cluster analysis [HCA
Publikováno v:
Omics : a journal of integrative biology. 8(3)
Mathematical models that reflect the effects of dietary restriction (DR) on the sera metabolome may have utility in understanding the mechanisms of DR and in applying this knowledge to human epidemiological studies. Previous studies demonstrated both
Publikováno v:
Omics : a journal of integrative biology. 8(3)
Our research seeks to identify a serum profile, or serotype, that reflects the systemic physiologic modifications resultant from dietary restriction (DR), in part such that this knowledge can be applied for biomarker studies. Direct comparison sugges
Autor:
Bruce S. Kristal, Ugo Paolucci
Publikováno v:
Science of aging knowledge environment : SAGE KE. 2003(27)
Caloric (or dietary) restriction (CR) is the most potent, robust, and reproducible known means of extending longevity and decreasing morbidity in laboratory mammals. Two of the major questions faced by researchers in this field are the applicability